Monopar Therapeutics Inc.
MNPR
$41.87
-$1.29-2.98%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 60.21M | 6.02M | 7.12M | 8.79M | 7.27M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 78.90K | 49.60K | 61.00K | 119.00K | 66.40K |
| Total Current Assets | 60.29M | 6.07M | 7.18M | 8.91M | 7.33M |
|
|
|||||
| Total Current Assets | 60.29M | 6.07M | 7.18M | 8.91M | 7.33M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | 12.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 60.29M | 6.07M | 7.18M | 8.91M | 7.35M |
|
|
|||||
| Total Accounts Payable | 2.25M | 1.12M | 1.09M | 1.44M | 1.76M |
| Total Accrued Expenses | 3.00M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.25M | 1.12M | 1.09M | 1.44M | 1.76M |
|
|
|||||
| Total Current Liabilities | 5.25M | 1.12M | 1.09M | 1.44M | 1.76M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.25M | 1.12M | 1.09M | 1.44M | 1.76M |
|
|
|||||
| Common Stock & APIC | 130.79M | 69.82M | 69.64M | 69.32M | 65.81M |
| Retained Earnings | -75.79M | -64.87M | -63.56M | -61.85M | -60.21M |
| Treasury Stock & Other | 36.00K | -11.00K | 8.30K | 4.20K | -14.10K |
| Total Common Equity | 55.04M | 4.95M | 6.09M | 7.48M | 5.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 55.04M | 4.95M | 6.09M | 7.48M | 5.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 55.04M | 4.95M | 6.09M | 7.48M | 5.59M |
|
|
|||||